XTalks

APRIL 17, 2024

In this episode, Ayesha spoke with Howard Berman, PhD, Founder and CEO of Coya Therapeutics , a clinical-stage biotech company developing regulatory T cell (Treg) therapies targeting neurodegenerative, autoimmune and metabolic diseases. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 111

Life Science Production Development 111

XTalks

JANUARY 17, 2024

Monogram is focused on developing patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. Ben is an engineer by training and before joining Monogram, he served as the Director of Business Development at Pro-Dex, an OEM manufacturer of Orthopedic Robotic End-Effectors.

Life Science 115

Life Science Engineer Business Development Manufacturing 115

XTalks

NOVEMBER 1, 2023

Stephanie Manson Brown, VP & Head of Clinical Development & Scientific Innovation of R&D at Allergan Aesthetics at AbbVie. Allergan Aesthetics is focused on creating products and technologies that drive the advancement of aesthetic medicine. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 105

Life Science Clinical Trials Clinical Trials Clinical Development 105

XTalks

JANUARY 20, 2022

Life science consulting can be a rewarding career and the job outlook is promising for the future. . Perhaps you have heard of life science consulting jobs but do not exactly know what type of work is involved, or the education and experience needed to become a life science consultant. Job Description.

Life Science 98

Life Science Production Marketing Big Data 98

XTalks

JULY 19, 2022

The life science industry is dynamic and progressive with 2022 exemplifying significant growth. Agile life science companies that were able to adapt to the challenges of the pandemic and ongoing global regulations prospered since the last two years.

Life Science 98

Life Science Regulation Vaccination Vaccine 98

pharmaphorum

DECEMBER 8, 2022

Life Sciences Council. Do you know about the Life Sciences Council (LSC)? The LSC has a website on Gov.uk, but the page says Life Sciences Council. A post from the director of health and life sciences at Innovate UK, Richard J Hebdon, also bigged up the news before the Council met about four health missions.

Life Science 105

Life Science Medicine Branding Research 105

Pharmaceutical Technology

AUGUST 15, 2022

It is no secret that Canada boasts a strong and competitive life sciences sector. Within Canada, one province has often stood out as the place to be for cutting-edge life sciences innovation. Canada’s next life sciences leader. Again, this is nothing new. Now, there is no slowing down.

Life Science 130

Life Science Research Manufacturing Insulin 130

Pharmaceutical Technology

MAY 23, 2023

Croda Pharma has entered a strategic collaboration deal with Botanical Solution Inc (BSI) to expedite the production of sustainable pharmaceutical-grade vaccine adjuvant QS-21. The plentiful supply of QS-21 enables the production of next-generation adjuvant systems for new vaccine development.”

Production 240

Production Vaccination Vaccine Life Science 240

Outsourcing Pharma

JUNE 7, 2023

With generative AI continuing to create a buzz, OSP took the opportunity to speak to Indegene, a digital-first, life sciences commercialization company that helps biopharmaceutical, emerging biotech and medical device companies develop products.

Life Science 75

Life Science Production Development Regulation 75

Drug Discovery World

SEPTEMBER 4, 2023

AviadoBio, a gene therapy company developing medicines for neurodegenerative disorders, will establish laboratory and office presence at the Innovation Centre. Kadans and Canary Wharf Group are also progressing their joint venture to develop an GIA commercial health and life sciences building, the largest in Europe, on the 3.3-hectare

Life Science 59

Life Science Gene Therapy Genome Genomics 59

Drug Channels

MARCH 28, 2024

Today’s guest post comes from Bill Dupere, SVP of Product Development & Partnerships at Mercalis. Bill discusses specialty therapy access barriers, including payer utilization management techniques and “no coverage” policies. Contact Mercalis to learn about their Patient Support Services. Read on for Bill’s insights.

Life Science 79

Life Science Marketing Production Development 79

XTalks

JUNE 26, 2023

Life science companies can position themselves as authoritative sources, create a community of loyal followers and influence purchasing decisions by leveraging content marketing strategies. This contributes substantially to achieving revenue goals in the life science industry.

Life Science 98

Life Science Marketing Sales Production 98

Drug Discovery World

MARCH 7, 2023

For International Women’s Day, DDW’s Diana Spencer celebrates some of the women in leadership making an impact on the drug discovery and life sciences sector. The life sciences sector has traditionally outperformed others when it comes to attracting women to its workforce. Anti-ageing science therefore has huge value.

Life Science 98

Life Science DNA Clinical Development Development 98

XTalks

MAY 1, 2024

In this episode, Ayesha spoke with Robert Barrow, CEO and Board Director at MindMed , a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders. After joining MindMed as Chief Development Officer in January 2021, he was named CEO in June 2021.

Life Science 52

Life Science Production Development Drugs 52

Pharmaceutical Technology

FEBRUARY 15, 2023

JSR Life Sciences’ business unit Similis Bio is planning to collaborate with Novel351k for the development of three biosimilar programmes targeting cancer and autoimmune diseases. Under the terms of the initial deal, Similis Bio will handle the development of cell lines, analytics, process development, and cGMP production.

Development 147

Development Life Science Manufacturing Clinical Trials 147

Drug Discovery World

MAY 9, 2023

Cytiva and the life sciences business of Pall Corporation have completed their integration and are now united as one business under the Cytiva brand. In January 2023, the life sciences business of Pall separated from Pall Corporation. Pall’s biotech portfolio is now a product family in Cytiva’s bioprocess business.

Life Science 52

Life Science Branding Manufacturing Production 52

XTalks

DECEMBER 20, 2023

In 2023, there were significant advancements and notable trends in the life sciences. These advancements and trends addressed important industry challenges and offered opportunities to foster innovations and solutions in areas including drug development, healthcare and medical devices. billion in 2022.

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

Drug Discovery World

JULY 4, 2023

Vesalius Biocapital, a life sciences venture capital investor, has closed its fourth fund, Vesalius Biocapital IV, securing over €95 million of commitments. The company plans to invest in first and best-in-class European life science companies in drug development and digital health.

Life Science 52

Life Science Sales Development Medicine 52

XTalks

MARCH 8, 2022

On International Women’s Day, Xtalks is celebrating women’s leadership in the life sciences by highlighting some of the female leaders at the forefront of scientific discovery, as well as the continuing challenges of attaining more equitable representation. Challenges in Women’s Leadership.

Life Science 105

Life Science Gene Therapy DNA Vaccination 105

XTalks

MAY 15, 2024

Ovid Therapeutics is a biopharmaceutical company focused on the development of medicines for epilepsies and seizure-related neurological disorders. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Phil, MB BChir, CEO and Chairman of Ovid Therapeutics Inc. ,

Life Science 69

Life Science Medicine Clinical Research Development 69

Drug Discovery World

MARCH 16, 2023

There was some good news for the UK life sciences sector in the government’s Spring Budget, but did it go far enough? DDW’s Diana Spencer takes a look at the industry’s reaction. There wasn’t much to write home about in the UK government’s Spring Budget, described by Bloomberg UK’s Marcus Ashworth as a “minimalist masterclass”.

Life Science 97

Life Science Regulation Medicine Research 97

BioTech 365

JUNE 7, 2021

Entegris Expands Life Sciences Production Capacity and Capabilities Entegris Expands Life Sciences Production Capacity and Capabilities The expansion of production facilities and development of a dedicated Life Sciences Technology Center address the increased demand for bioprocessing assemblies.

Life Science 52

Life Science Production Development 52

pharmaphorum

DECEMBER 21, 2022

Two-thirds – 67% – of life sciences companies surveyed had not set a Net Zero target in 2022. Of those companies that set Net Zero targets, the life sciences sector has an average target for 2037 – 11 years earlier than the cross-sector average of 2048. But there is also reason for optimism in the face of this challenge.

Life Science 98

Life Science DNA Production Development 98

XTalks

MAY 8, 2024

Dr. Schaffner and Dr. Moore discussed the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) recommendation of a trivalent influenza vaccine strain selection, as opposed to a typical quadrivalent vaccine, with the 2024/2025 influenza season reflecting the removal of the B/Yamagata strain.

Life Science 95

Life Science Vaccination Vaccine Medicine 95

pharmaphorum

MARCH 8, 2022

How did you get into life sciences? Our products are used primarily in the fight against cancer – to aid drug discovery – while also ensuring patients and laboratory workers are safe. Why is it important to encourage girls and young women to pursue life sciences roles? What has your career path been?

Life Science 98

Life Science Engineer Scientist Doctors 98

Drug Discovery World

MAY 10, 2023

PerkinElmer’s Life Sciences division has revealed its new name and branding. Revvity has now officially launched as a science-based solutions company. Franchises, BioLegend, EUROIMMUN, Tulip Diagnostics and ViaCord will retain their own names as unique product lines.

Life Science 52

Life Science Reagent Genome Genomics 52

BioTech 365

MAY 20, 2021

Istari Oncology Honored as “Best Early Stage Product Development Company” in the Triangle Business Journal’s Life Sciences Awards Istari Oncology Honored as “Best Early Stage Product Development Company” in the Triangle Business Journal’s Life Sciences Awards RALEIGH, N.C.–(BUSINESS

Life Science 52

Life Science Production Development 52

Pharmaceutical Technology

MAY 24, 2023

Forge Biologics has joined the public-private collaboration, the Bespoke Gene Therapy Consortium (BGTC), to expedite the development and manufacture of new AAV [adeno-associated virus] gene therapies to treat patients with rare diseases. Shilling was appointed to represent the company on the steering committee of the BGTC.

Gene Therapy 242

Gene Therapy Gene Development Manufacturing 242

XTalks

FEBRUARY 15, 2023

Bastiaan Driehuys, PhD Founder and Chief Technology Officer Polarean Imaging plc In this week’s Xtalks Life Science podcast episode, Ayesha and the editorial team spoke with Dr. Bastiaan Driehuys, Founder and Chief Technology Officer at Polarean Imaging plc. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 98

Life Science FDA Approval Drugs Production 98

Drug Discovery World

MAY 10, 2023

PerkinElmer’s Life Science and Diagnostics business has revealed its new name and branding. Revvity has now officially launched as a science-based solutions company. Franchises, BioLegend, EUROIMMUN, Tulip Diagnostics and ViaCord will retain their own names as unique product lines.

Life Science 52

Life Science Reagent Genome Genomics 52

Pharmaceutical Technology

NOVEMBER 7, 2022

As a vertically integrated company, SHL Medical prides itself on being an end-to-end partner, offering in-house capabilities at every stage – from design, development and production to final assembly, labelling and packaging. The company’s most prominent products are its autoinjectors, which are seeing growing global demand.

Production 130

Production Life Science Manufacturing Drug Delivery Systems 130

pharmaphorum

APRIL 4, 2022

Multinational insurance company AXA has launched a new €440 million ($500 million) drive to provide private equity investments in healthcare companies that deepens its interest in the life sciences sector. It is a major backer of Kadans, one of the groups behind the recently-announced Canary Wharf life sciences hub in east London.

Life Science 59

Life Science Vaccination Vaccine Marketing 59

XTalks

MARCH 6, 2024

MBA, Vice President, Global Head of Marketing, Sight Sciences, about the evolving field of eye care. Sight Sciences is focused on developing and commercializing innovative solutions for eye diseases like glaucoma and dry eye disease to transform care and improve patients’ lives. In this episode, Ayesha spoke with H.

Life Science 52

Life Science Marketing Doctors Doctor 52

XTalks

DECEMBER 29, 2022

The life sciences and healthcare are among the biggest industries globally, and their significance was particularly highlighted during the past couple of years by the COVID-19 pandemic. Given the hyperfocus on the life sciences thanks to COVID, consumers appear to be more autonomous and vocal about their medical demands and choices.

Life Science 52

Life Science Gene Therapy Gene Manufacturing 52

pharmaphorum

OCTOBER 1, 2020

But things are changing and women are becoming more influential in life sciences VCs, with an increase in business going to all-female teams. The story was slightly different in life sciences, however: all-female teams in biotech and pharma received 10% of funding compared with 7% for all-male”.

Life Science 122

Life Science Engineer Production Research 122

XTalks

DECEMBER 13, 2023

This episode features an interview with vaccine scientists and executives from Vaccines Global Clinical Development at Merck, Dr. Heather Platt, MD, Distinguished Scientist and Pneumococcal Vaccine Lead; and Dr. Ulrike Buchwald, MD, Scientific Associate Vice President, Global Clinical Research and Pneumococcal Vaccine Section Head.

Life Science 52

Life Science Vaccination Vaccine Scientist 52

Drug Discovery World

MARCH 6, 2023

Assisted by a dedicated scientific advisor, a leadership coach and a BII business development expert, the new ventures will be guided in developing a detailed milestone plan and will be assisted in overcoming the challenges of growing a business. million in follow-up funding through BII’s Venture House program.

Life Science 52

Life Science RNA Drugs Business Development 52